CME webinar: Screening and Assessment for Suicide Prevention
Sep. 2022Education/Webinars
"September is National Suicide Awareness Month, and you are invited to watch a timely recorded webinar on the topic. Andrei Nemoianu, MD, Regional Medical Director, Community Care Behavioral Health Organization, discusses:
*This activity is approved for AMA PRA Category 1 Credit™ and ANCC. Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
*Provider is responsible for verifying CME eligibility."
- How to define suicide screening and identify how often it should be used.
- Suicide assessment and when it should be done.
- How to gain greater familiarity with formulating a suicide risk assessment.
- Three suicide screening tools.
- How to locate resources to help develop a policy around suicide screening and assessment.
*This activity is approved for AMA PRA Category 1 Credit™ and ANCC. Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
*Provider is responsible for verifying CME eligibility."
Recent Announcements
Voluntary nationwide recall: Famotidine (Fresenius – November)
Fresenius Kabi USA, LLC is recalling three lots (6133156, 6133194, and 6133388) of Famotidine Injection, USP, 20 mg per 2 mL. Famotidine is used to treat excessive secretion of stomach acid or stomach ulcers.Nov. 2025Pharmacy Updates
Medicaid provider update: High-cost Medicaid drug billing
Billing requirements for Medicaid-covered drugsNov. 2025Important Notices
Training Webinar: Conversio Health COPD Management Program
Please join us for a live training webinar for primary care providers and pulmonologists by UPMC Health Plan that will provide an overview of a comprehensive COPD management program from Conversio Health.Nov. 2025Education/Webinars